Neuropathic Charcot arthropathy is a complication of diabetes mellitus which in a high percentage of patients leads to foot fracture, joint destruction (subluxation and/or dislocation), severe foot deformity, ulceration, instability, and possibly amputation. Early detection and timely intervention are necessary to minimize the severe consequences of this increasingly prevalent condition. The development of new treatments is currently limited, however, by the lack of biomarkers that are sensitive and specific indicators of neuropathic Charcot arthropathy disease onset and treatment outcomes. Our long term goals are to improve neuropathic Charcot arthropathy treatments and to identify subjects who are at high risk for developing this debilitating complication. There is evidence that those with neuropathic Charcot arthropathy have low foot bone mineral densities (BMDs) and that foot BMDs further decrease during off-loading treatment. The objectives of this pilot data application are to establish volumetric quantitative computed tomography (VQCT)-derived foot BMD as a candidate biomarker for acute neuropathic Charcot arthropathy and to collect preliminary data for sample-size calculations in support of future studies to qualify foot BMD as a biomarker of neuropathic Charcot arthropathy. This pilot grant application has two specific aims: 1) to demonstrate the extent to which VQCT-derived foot BMDs predict treatment outcomes in subjects with diabetes mellitus, peripheral neuropathy, and acute neuropathic Charcot arthropathy and 2) determine the feasibility of using VQCT-derived foot BMDs to assess the risk of developing neuropathic Charcot arthropathy in subjects with diabetes mellitus and peripheral neuropathy.
These specific aims will be achieved through a repeated measures cohort study in which clinical and radiological data will be collected: (1) at baseline, three months, six months and yearly for subjects who have neuropathic Charcot arthropathy and are undergoing the standard off-loading treatment protocol (Aim 1), and (2) at baseline and yearly for subjects with diabetes and peripheral neuropathy but who have not developed neuropathic Charcot arthropathy (Aim 2). Analysis of the baseline and follow-up changes will determine the extent to which VQCT-derived foot BMDs are indicators of treatment outcomes (Aim 1).
Aim 2 subjects will be compared to Aim 1 subjects to determine the ability of volumetric foot BMD to estimate the risk for developing neuropathic Charcot arthropathy. Developing biomarkers in this area is significant because it can lead to identifying subjects at risk for developing neuropathic Charcot arthropathy and support the development of new treatment regimens that reduce the number of severe complications for this important patient group. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DK079457-02
Application #
7467375
Study Section
Special Emphasis Panel (ZDK1-GRB-N (M1))
Program Officer
Jones, Teresa L Z
Project Start
2007-08-01
Project End
2010-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
2
Fiscal Year
2008
Total Cost
$297,920
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Commean, Paul K; Smith, Kirk E; Hildebolt, Charles F et al. (2018) A Candidate Imaging Marker for Early Detection of Charcot Neuroarthropathy. J Clin Densitom 21:485-492
Sinacore, David R; Bohnert, Kathryn L; Smith, Kirk E et al. (2017) Persistent inflammation with pedal osteolysis 1year after Charcot neuropathic osteoarthropathy. J Diabetes Complications 31:1014-1020
Gelber, Judith R; Sinacore, David R; Strube, Michael J et al. (2014) Windlass Mechanism in Individuals With Diabetes Mellitus, Peripheral Neuropathy, and Low Medial Longitudinal Arch Height. Foot Ankle Int 35:816-824
Liu, Lu; Commean, Paul K; Hildebolt, Charles et al. (2013) Automated, foot-bone registration using subdivision-embedded atlases for spatial mapping of bone mineral density. J Digit Imaging 26:554-62
Bohnert, Kathryn L; Gutekunst, David J; Hildebolt, Charles F et al. (2013) Dual-energy X-ray absorptiometry of human metatarsals: precision, least significant change and association to ex vivo fracture force. Foot (Edinb) 23:63-9
Gutekunst, David J; Patel, Tarpit K; Smith, Kirk E et al. (2013) Predicting ex vivo failure loads in human metatarsals using bone strength indices derived from volumetric quantitative computed tomography. J Biomech 46:745-50
Gutekunst, David J; Sinacore, David R (2013) Pedal bone density, strength, orientation, and plantar loads preceding incipient metatarsal fracture after charcot neuroarthropathy: 2 case reports. J Orthop Sports Phys Ther 43:744-51
Hastings, Mary K; Johnson, Jeffrey E; Strube, Michael J et al. (2013) Progression of foot deformity in Charcot neuropathic osteoarthropathy. J Bone Joint Surg Am 95:1206-13
Gutekunst, David J; Smith, Kirk E; Commean, Paul K et al. (2013) Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices. Bone 52:407-13
Smith, K E; Whiting, B R; Reiker, G G et al. (2012) Assessment of technical and biological parameters of volumetric quantitative computed tomography of the foot: a phantom study. Osteoporos Int 23:1977-85

Showing the most recent 10 out of 19 publications